The aptamers had modifications of 2-fluoro pyrimidine (2-F Py), dithiophosphate, and polyethylene glycol (PEG), which significantly increased their resistance to nuclease degradation, decreased renal clearance, and enhanced pharmacokinetic characteristics
Key Takeaways for Providers Standard GLP-1 therapies are highly effective for appetite regulation but often fail to address metabolic adaptation, leading to weight loss plateaus
Fun fact from a data deep dive that I helped work on: Medicaid spending on GLP-1s has grown exponentially over the past five years with 36 states now covering at least one of the FDA-approved GLP-1s for obesity (Wegovy, Zepbound, or Saxenda) Why
GHK-Cu Storage & Handling Storage Reference State Lyophilized (Powder Form) Storage -4F (-20C) long-term
2001 Sep- Oct;17(5):401-14
This may be particularly attractive for individuals looking to support internal detox pathways or for those pursuing cosmetic or wellness goals under the care of a licensed provider